Добавил:
shahzodbeknormurodov27@gmail.com Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Practical Urology ( PDFDrive ).pdf
Скачиваний:
12
Добавлен:
27.08.2022
Размер:
25.91 Mб
Скачать

355

HEmatUria: EvalUation and managEmEnt

concomitant underlying urological pathology.

eGFR should also be measured as an indicator

Patients symptomatic of a urinary tract infection

of renal impairment.

should receive a course of antibiotics and the flex-

 

ible cystoscopy should be postponed for a couple

Flexible Cystoscopy

of weeks in order to allow the urinary tract infec-

tion to be fully treated.

Flexible cystoscopy under local anesthetic is prob-

The use of routine urinalysis as a screening

ably the ideal way to investigate the lower urinary

tool for urological malignancy remains the sub-

tract for hematuria. It combines good patient tol-

ject of debate.While the detection of microscopic

erability with safety and low cost, and the views

hematuria at urinalysis may predict the develop-

are usually as good as those obtained with a rigid

ment of bladder cancer,19 there is also evidence

instrument.23 Cystoscopy reportedly has a 5% risk

that patients testing positive and negative for

of causing urinary infection.37 Of note, the ability

microscopic hematuria have an equal chance of

of flexible cystoscopy to detect CIS of the bladder

developing a urological malignancy.24 A routine

may be more limited than with rigid instrumen-

screening program for urological malignancy

tation.38 If a bladder or urethral tumor is found at

based on urinalysis and the detection of hematu-

flexible cystoscopy, the patient should undergo

ria is therefore not currently advocated.

examination under anesthesia and formal tran-

 

Cytology

surethral resection, together with upper tract

evaluation (see below) including an intravenous

Urine cytology can detect atypical or malignant

urogram (IVU) or, increasingly commonly, a con-

trast-enhanced computer tomography urogram

cells but its sensitivity depends upon numerous

(CTU), in order to detect a synchronous urothe-

factors including the grade of the urothelial

lial lesion elsewhere within the urinary tract.

malignancy and the experience of the reporting

 

pathologist.5 It has a high specificity for the

 

detection of high-grade urothelial tumors and

Upper Urinary Tract Evaluation

CIS,25 but can be positive with nonmalignant

Evaluation of the upper urinary tract is complex

conditions such as chronic infection or inflam-

mation and urinary calculus disease.23

and requires a balance between the number of

 

radiological investigations required to detect

Molecular Tests

significant pathology and the low detection rate

of each test (Fig. 26.1). This balance varies

 

Recently, numerous molecular tests have been

between institutions (reflecting that no single

designed to detect urothelial malignancy using

protocol is ideal), and depends upon the indi-

urine analysis.25 The most developed of these are

vidual patient’s pathological risks (established

the detection of bladder tumor antigen (BTA),26-28

from history and examination) and their medi-

nuclear matrix protein 22 (NMP22),29-32 and fluo-

cal comorbidity. For example, unfit patients

rescence in-situ hybridization for chromosomal

may not benefit from investigations that would

anomalies (UroVysion). The NMP22 test is one of

not alter their management even if pathology

the best evaluated and detects the NMP22 protein

was found. Many urologists adopt a pragmatic

which is present at significantly greater con-

approach and utilize a renal ultrasound (USS)

centration in the urine of patients with bladder

scan in order to detect renal parenchymal

cancer as compared with normal controls.25

lesions and a plain abdominal x-ray for calculi.

NMP22 detection has a sensitivity between 58%

If flexible cystoscopy and these radiological

(specificity 84%) and 91% (specificity 76%) in

tests are normal, then patients with macro-

reported studies.32-36 Data suggest that it should

scopic or persistent microscopic hematuria

be used to complement a flexible cystoscopy.

should probably undergo additional upper tract

 

imaging in the form of either an IVU or CTU. If

Blood Tests

these investigations are negative and the patient

continues to have frank hematuria, additional

A full blood count should be considered in

investigations may be required,depending upon

patients with heavy or long-standing hematuria

the index of suspicion of a malignant cause of

to detect anemia, while plasma creatinine and

hematuria.

356

Practical Urology: EssEntial PrinciPlEs and PracticE

Figure 26.1. algorithm for the investigation of hematuria. in all patients, a full history should be elicited and an abdominal and pelvic examination should be performed in addition to urinary testing (to check for red cells, white blood cells, infection, and atypical cytology). additional hematological and biochemical blood tests are also usually required. CTU ct urogram, IVU intravenous urography, USS abdominal and pelvic ultrasound, UTI urinary tract infection, LUTS lower urinary tract symptoms.

 

 

 

 

Hematuria

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Microscopic

 

Also investigate other symptoms:

 

Macroscopic

 

hematuria

 

e.g. Non-contrast CT for renal

 

hematuria

 

 

 

colic or uroflowmetry for LUTS

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

UTI

 

 

 

 

No UTI

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Male or recurrent

 

 

 

 

 

 

 

 

 

 

UTI: Treat UTI

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Female and

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

occasional

 

 

- Cystoscopy

 

 

UTI: Treat

 

 

 

 

 

 

- USS and x-ray

 

 

UTI then

 

 

 

 

 

 

+/- IVU or CTU

 

 

retest urine

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Ongoing hematuria:

-Cystoscopy

-USS and x-ray +/- IVU or CTU

-Cystoscopy

-USS and x-ray +/- IVU or CTU

Persistant hematuria or high-risk features: Consider

-Retrograde studies

-Angiography

Renal USS

Ultrasound is a relatively cheap, safe, and noninvasive investigation. While it is useful for the detection of renal parenchymal lesions such as renal tumors, characterization of renal cysts, and the detection of hydronephrosis,39 it has a limited ability to detect solid renal lesions less than 3 cm in size40 or small tumors within the urinary collecting system. CT is required for the further characterization of complex renal cysts (contrast enhanced) or stones (noncontrast). The ureter is often not well visualized with USS.

KUB Abdominal X-Ray

In many centers, a plain abdominal x-ray is used in the initial assessment of hematuria to detect urinary calculi. This is a pragmatic choice as it avoids the added radiation exposure of an IVU or CT scan, but can miss many urinary stones and doesn’t help in ureteric or renal pelvis visualization. Patients with suspected urinary calculi should undergo a noncontrast CT. Patients with features suggesting high malignancy risk (such as advanced age, strong history of smoking or occupational carcinogen exposure, or macroscopic

hematuria) should undergo more thorough upper tract radiological imaging

Intravenous Urography (IVU)

While an IVU is useful for the detection of abnormalities of the upper urinary tract such as UCC,41 calculi,and hydronephrosis,it exposes the patient to nephrotoxic contrast media and is contra-indicated in renal insufficiency. An IVU has limited sensitivity for detecting small renal masses42 and is not as accurate as USS at identifying small renal parenchymal lesions.5 Therefore, an IVU should be used in conjunction with a renal USS. If a mass is detected by IVU, the lesion should be further characterized by either USS or CT. A recent study of 1,930 patients found that 9.4% of the patients with microscopic hematuria had cancer, and that evaluation of the upper urinary tract with one imaging modality alone would miss an upper tract malignancy in 4 patients.2 In many centres in the United Kingdom and elsewhere USS and IVU have now been replaced by CTU as the first-line investigation of the upper tract in patients with macroscopic hematuria.